1200 related articles for article (PubMed ID: 10353401)
41. In vitro testing for carcinogens and mutagens.
Santella RM
Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
[TBL] [Abstract][Full Text] [Related]
42. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
[TBL] [Abstract][Full Text] [Related]
43. The challenge of testing chemicals for potential carcinogenicity using multiple short-term assays: an analysis of a proposed test battery for hair dyes.
Rosenkranz HS; Cunningham SL; Mermelstein R; Cunningham AR
Mutat Res; 2007 Sep; 633(1):55-66. PubMed ID: 17625954
[TBL] [Abstract][Full Text] [Related]
44. Screening assays for carcinogenic agents and mixtures: an appraisal based on data in the IARC Monograph series.
Bartsch H; Malaveille C
IARC Sci Publ; 1990; (104):65-74. PubMed ID: 2228144
[TBL] [Abstract][Full Text] [Related]
45. [Characteristics of genotoxic and carcinogenic action of metals].
Maksimchuk TP; Babenko GA
Eksp Onkol; 1990; 12(4):3-9. PubMed ID: 2199186
[TBL] [Abstract][Full Text] [Related]
46. Mutation research, genetic toxicology and environmental mutagenesis.
Martus HJ; Suter W
Mutat Res; 2009 Jan; 672(2):135. PubMed ID: 19056513
[No Abstract] [Full Text] [Related]
47. The proportions of mutagens among chemicals in commerce.
Zeiger E; Margolin BH
Regul Toxicol Pharmacol; 2000 Oct; 32(2):219-25. PubMed ID: 11067778
[TBL] [Abstract][Full Text] [Related]
48. Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs.
Bartsch H; Tomatis L
Environ Health Perspect; 1983 Jan; 47():305-17. PubMed ID: 6337827
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.
Kamber M; Flückiger-Isler S; Engelhardt G; Jaeckh R; Zeiger E
Mutagenesis; 2009 Jul; 24(4):359-66. PubMed ID: 19447896
[TBL] [Abstract][Full Text] [Related]
50. Comparison of carcinogenic and in vivo genotoxic potency estimates.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
[TBL] [Abstract][Full Text] [Related]
51. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
Butterworth BE
Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
[TBL] [Abstract][Full Text] [Related]
52. Classification of chemicals for carcinogenic and mutagenic properties.
Kramers PG; Roelfzema H
Toxicol Lett; 1992 Dec; 64-65 Spec No():173-82. PubMed ID: 1471172
[TBL] [Abstract][Full Text] [Related]
53. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
[TBL] [Abstract][Full Text] [Related]
54. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
55. Use of tests in yeasts and fungi in the detection and evaluation of carcinogens.
Parry JM
IARC Sci Publ; 1999; (146):471-85. PubMed ID: 10353399
[No Abstract] [Full Text] [Related]
56. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
[TBL] [Abstract][Full Text] [Related]
57. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
[TBL] [Abstract][Full Text] [Related]
59. Animal carcinogenicity studies: implications for the REACH system.
Knight A; Bailey J; Balcombe J
Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
[TBL] [Abstract][Full Text] [Related]
60. What's new in mutagenicity and carcinogenicity--status of short-term assay systems as tools in genetic toxicology and carcinogenesis.
Pool BL; Schmähl D
Pathol Res Pract; 1987 Oct; 182(5):704-12. PubMed ID: 3317326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
